PDF herunterladen
Am J Perinatol 2021; 38(09): 960-967
DOI: 10.1055/s-0040-1701196
Original Article

Accuracy and Interobserver Reliability of Magnetic Resonance Imaging for Placenta Accreta Spectrum Disorders

Brett D. Einerson
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah
2   Department of Obstetrics and Gynecology, Intermountain Healthcare, Salt Lake City, Utah
,
Christina E. Rodriguez
3   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado
,
Robert M. Silver
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah
2   Department of Obstetrics and Gynecology, Intermountain Healthcare, Salt Lake City, Utah
,
Meghan A. Donnelly
3   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado
,
Anne M. Kennedy
4   Department of Radiology, University of Utah Health, Salt Lake City, Utah
,
Paula J. Woodward
4   Department of Radiology, University of Utah Health, Salt Lake City, Utah
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Objective This study aims to define the accuracy, predictive value, and interobserver reliability of magnetic resonance imaging (MRI) in the diagnosis of placenta accreta spectrum (PAS) disorders.

Study Design Two experienced radiologists independently interpreted the MRI studies of patients with possible PAS from two referral centers. Radiologists were blinded to sonographic and clinical information. We calculated diagnostic testing characteristics and kappa statistics of interobserver reliability for MRI findings of PAS.

Results Sixty-eight MRI cases were evaluated. Confirmed PAS and severe PAS were present in 44 (65%) and 20 (29%) cases. For the diagnosis of any PAS, MRI had a sensitivity 66%, specificity 71%, positive predictive value (PPV) 81%, negative predictive value (NPV) 53%, and accuracy 68%. For the diagnosis of severe PAS (percreta), MRI had a sensitivity 85%, specificity 79%, PPV 63%, NPV 93%, and accuracy 81%. The accuracy of individual signs of PAS was lower (44–65%). Interobserver agreement was almost perfect for previa; substantial for myometrial interruptions, PAS, severe PAS, and placental bulging/balling; and moderate to slight for other signs of PAS.

Conclusion Although the interobserver reliability of MRI for a diagnosis of PAS is substantial, the accuracy and predictive value are modest and lower than previously reported.

Keywords

accreta - diagnosis - magnetic resonance imaging - placenta accreta spectrum

Note

These study findings were presented at the Society for Maternal-Fetal Medicine meeting in Las Vegas, Nevada, January 23 to 27, 2017.




Publikationsverlauf

Eingereicht: 28. Juli 2019

Angenommen: 16. Dezember 2019

Artikel online veröffentlicht:
27. Januar 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005; 192 (05) 1458-1461
    CrossrefPubMedSuche in Google Scholar
  • 2 Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med 2016; 29 (07) 1077-1082
    CrossrefPubMedSuche in Google Scholar
  • 3 Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand 2011; 90 (10) 1140-1146
    CrossrefPubMedSuche in Google Scholar
  • 4 Eller AG, Bennett MA, Sharshiner M. et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117 (2 Pt 1): 331-337
    CrossrefPubMedSuche in Google Scholar
  • 5 Shamshirsaz AA, Fox KA, Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212 (02) 218.e1-218.e9
    CrossrefPubMedSuche in Google Scholar
  • 6 Bartels HC, Rogers AC, O'Brien D, McVey R, Walsh J, Brennan DJ. Association of Implementing a Multidisciplinary Team Approach in the Management of Morbidly Adherent Placenta With Maternal Morbidity and Mortality. Obstet Gynecol 2018; 132 (05) 1167-1176
    CrossrefPubMedSuche in Google Scholar
  • 7 Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet 2018; 140 (03) 274-280
    CrossrefPubMedSuche in Google Scholar
  • 8 Placenta accreta spectrum. Obstetric care consensus no. 7. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018; 132: 259-275
    CrossrefPubMedSuche in Google Scholar
  • 9 Budorick NE, Figueroa R, Vizcarra M, Shin J. Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta. J Matern Fetal Neonatal Med 2017; 30 (20) 2422-2427
    CrossrefPubMedSuche in Google Scholar
  • 10 Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, Sisodia RC, Gervais DA, Lee SI. MRI of placenta accreta, placenta increta, and placenta percreta: pearls and pitfalls. AJR Am J Roentgenol 2017; 208 (01) 214-221
    CrossrefPubMedSuche in Google Scholar
  • 11 Jauniaux E, Alfirevic Z, Bhide AG. et al; Royal College of Obstetricians and Gynaecologists. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG 2019; 126 (01) e1-e48
    CrossrefPubMedSuche in Google Scholar
  • 12 Collins SL, Alemdar B, van Beekhuizen HJ. et al; International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the international society for abnormally invasive placenta. Am J Obstet Gynecol 2019; 220 (06) 511-526
    CrossrefPubMedSuche in Google Scholar
  • 13 Cal M, Ayres-de-Campos D, Jauniaux E. International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2018; 140 (03) 307-311
    CrossrefPubMedSuche in Google Scholar
  • 14 D'Antonio F, Iacovella C, Palacios-Jaraquemada J, Bruno CH, Manzoli L, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44 (01) 8-16
    CrossrefPubMedSuche in Google Scholar
  • 15 Familiari A, Liberati M, Lim P. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2018; 97 (05) 507-520
    CrossrefPubMedSuche in Google Scholar
  • 16 Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol 2018; 218 (06) 618.e1-618.e7
    CrossrefPubMedSuche in Google Scholar
  • 17 Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005; 37 (05) 360-363
    PubMedSuche in Google Scholar
  • 18 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (01) 159-174
    CrossrefPubMedSuche in Google Scholar
  • 19 Palacios-Jaraquemada JM, Bruno CH, Martín E. MRI in the diagnosis and surgical management of abnormal placentation. Acta Obstet Gynecol Scand 2013; 92 (04) 392-397
    CrossrefPubMedSuche in Google Scholar
  • 20 Goergen SK, Posma E, Wrede D. et al. Interobserver agreement and diagnostic performance of individual MRI criteria for diagnosis of placental adhesion disorders. Clin Radiol 2018; 73 (10) 908.e1-908.e9
    CrossrefPubMedSuche in Google Scholar
  • 21 Ueno Y, Maeda T, Tanaka U. et al. Evaluation of interobserver variability and diagnostic performance of developed MRI-based radiological scoring system for invasive placenta previa. J Magn Reson Imaging 2016; 44 (03) 573-583
    CrossrefPubMedSuche in Google Scholar
  • 22 Valentini AL, Gui B, Ninivaggi V. et al. The morbidly adherent placenta: when and what association of signs can improve MRI diagnosis? Our experience. Diagn Interv Radiol 2017; 23 (03) 180-186
    CrossrefPubMedSuche in Google Scholar
  • 23 Chen T, Xu XQ, Shi HB, Yang ZQ, Zhou X, Pan Y. Conventional MRI features for predicting the clinical outcome of patients with invasive placenta. Diagn Interv Radiol 2017; 23 (03) 173-179
    CrossrefPubMedSuche in Google Scholar
  • 24 Delli Pizzi A, Tavoletta A, Narciso R. et al. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome. Abdom Radiol (NY) 2019; 44 (05) 1873-1882
    CrossrefPubMedSuche in Google Scholar
  • 25 Morel O, Collins SL, Uzan-Augui J. et al; International Society for Abnormally Invasive Placenta (IS-AIP). A proposal for standardized magnetic resonance imaging (MRI) descriptors of abnormally invasive placenta (AIP) - From the International Society for AIP. Diagn Interv Imaging 2019; 100 (06) 319-325
    CrossrefPubMedSuche in Google Scholar